Immune checkpoint inhibition: prospects for prevention and therapy of hepatocellular carcinoma

The global prevalence of liver cancer is rapidly rising, mostly as a result of the amplified incidence rates of viral hepatitis, alcohol abuse and obesity in recent decades. Treatment options for liver cancer are remarkably limited with sorafenib being the gold standard for advanced, unresectable he...

Descripción completa

Detalles Bibliográficos
Autores principales: Elsegood, Caryn L, Tirnitz-Parker, Janina EE, Olynyk, John K, Yeoh, George CT
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704099/
https://www.ncbi.nlm.nih.gov/pubmed/29326816
http://dx.doi.org/10.1038/cti.2017.47

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704099/
https://www.ncbi.nlm.nih.gov/pubmed/29326816
http://dx.doi.org/10.1038/cti.2017.47

Ejemplares similares